CannIntelligence open content

Insurance rule ‘a billion-dollar shot in the arm’ for Colombian cannabis market

Written by CannIntelligence | 11th January 2022

Colombian insurance providers must now cover the cost of medical cannabis prescriptions, a move that could represent a “billion-dollar shift” in the market – and perhaps lay down a marker for other countries ...

Colombian insurance policy shows real intent to lead on cannabinoids

Written by Freddie Dawson | 6th January 2022

Colombia has joined a select few countries now demanding mandatory coverage of medical cannabis by health insurance providers ...

Rival bills aim to establish a pathway to the US market for ingestible CBD

Written by CannIntelligence | 3rd January 2022

US representatives have introduced a bill into the House aiming to push the US Food and Drug Administration (FDA) to regulate CBD in food and drinks ...

CBD-Intel’s crystal ball reveals possible intoxicating prospects for the year ahead

Written by Freddie Dawson | 29th December 2021

“Intoxicating” will be the word to watch for and THC will be the main driver for developments in 2022, CBD-Intel predicts ...

Legal eagle Kight explains how the USPS could have modified PACT Act regulation

Written by CannIntelligence | 22nd December 2021

Does the United States Postal Service (USPS) really have the authority to permit the shipping of CBD vaping products under the PACT Act? ...

Arby Barroso talks about the future of CBD and nutraceuticals on the CBD-Intel podcast

Written by JuditBach | 21st December 2021

CBD-Intel podcast editor Jon Bruford meets Green Roads advocate, Arby Barroso, who talks about the future of CBD and...

Florida bill will not distinguish delta-8 THC from other hemp-derived products

Written by Freddie Dawson | 16th December 2021

There are incorrect reports that a proposed bill in Florida would regulate delta-8 THC products in the state. In fact the bill will place limitations on the sale of all hemp-derived products ...

UK health trust teams up with Awakn to investigate psychedelic treatment

Written by Lorraine Mullaney | 13th December 2021

The UK’s National Health Service (NHS) has expressed some interest in the viability of psychedelics as a course of treatment ...

What do Luxembourg and Malta’s legal cannabis plans mean in practice?

Written by Freddie Dawson | 9th December 2021

Will proposed plans to legalise recreational cannabis in Luxembourg and Malta change much in terms of EU business? ...

Little stands in the way of Germany legalising recreational cannabis by 2024

Written by CannIntelligence | 30th November 2021

The incoming German ‘traffic light’ coalition government’s promise to legalise recreational cannabis for adults puts it on track to be the first major European nation to take such action ...

Podcast: A UK doctor’s take on CBD

Written by CBD-Intel | 25th November 2021

CBD-Intel podcast editor Jon Bruford meets Dr K CBD's Dr Ruchira Karunadasa who explains why he believes the company has an important role to play in helping the industry towards mature dialogue, and the impact...

New German coalition plans to legalise cannabis – but when will sales begin?

Written by Freddie Dawson | 25th November 2021

The newly elected German governing coalition has followed through on pre-election promises and included a plan for cannabis legalisation in its coalition agreement – but many questions remain to be answered ...

European Commission commentary on French CBD rules raises wider questions

Written by CannIntelligence | 19th November 2021

Questions on European policies banning flowers and outlining permitted THC levels in food ingredients have been raised by a commentary from the EC to a French proposal ...

Why are specialist vape retailers around the world turning away from CBD online?

Written by Freddie Dawson | 17th November 2021

More and more vape specialists appear to be moving away from selling CBD vaping products, according to online market data produced by CBD-Intel ...

Gupta’s appointment and nomination of Califf may indicate change in US climate

Written by Freddie Dawson | 16th November 2021

Rahul Gupta has been confirmed by the US Senate as director of National Drug Control Policy, while president Joe Biden intends to nominate Robert Califf as head of the US Food and Drug Administration (FDA)...

eBay prepares to take on Amazon with the launch of UK trial of CBD sales

Written by Freddie Dawson | 10th November 2021

eBay is set to launch a CBD trial, sources tell CBD-Intel. The internet marketplace that built its name as an auction site is said to be anticipating a November start for its UK...

The suspense continues, still with no end in sight to the UK’s novel food saga

Written by Freddie Dawson | 3rd November 2021

October has ended and November begun with still no further update from the UK Food Standards Agency (FSA) on the ongoing novel food application...

Concerns arise as Italian study finds pesticides and metals in hemp flowers

Written by CannIntelligence | 29th October 2021

Another study, this time from Italy, has found potentially dangerous levels of heavy metals and pesticides in CBD products. Researchers were worried by the results and asked regulators and legislators to act ...

Court of Cassation ruling spreads more confusion over French legal position

Written by CannIntelligence | 25th October 2021

The highest court in France has confirmed the decision made by the EU Court of Justice (CJEU) in the Kanavape case – but the decision has contributed to uncertainty over the legality of hemp-derived...

Brazilian report highlights theoretical growth but small current numbers

Written by CannIntelligence | 22nd October 2021

Interest in the Brazilian medical cannabinoid market is based on optimistic projections of growth continuing in the same vein rather than concrete current numbers, a domestic report has confirmed ...